Stay updated on Pembrolizumab in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Pancreatic Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision updated from v3.5.4 to v3.5.5, signaling a small update to the page. The change appears to be a version bump without visible content edits.
    Difference
    0.1%
    Check dated 2026-06-05T12:23:07.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.3 to v3.5.4, representing a newer version of the page. It is a metadata/version update and does not reflect a substantive change to study content.
    Difference
    0.1%
    Check dated 2026-05-15T05:25:43.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Updates the ClinicalTrials.gov page “Revision” from v3.5.2 to v3.5.3, reflecting a platform/version release rather than any change to the underlying study record.
    Difference
    0.1%
    Check dated 2026-04-24T05:56:51.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:47:02.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0; no study details or outcomes appear to be affected.
    Difference
    0.1%
    Check dated 2026-03-19T06:12:16.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T02:17:56.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Pancreatic Cancer Clinical Trial page.